Photo of Jeff Gold, M.D.

Jeff Gold M.D.

Dr. Gold’s research focuses on the understanding the usability of Electronic Health Records in the ICU, specifically focused on the ability to use simulated patient charts to create high-fidelity EHR training exercises as well as provide a test bed to objectively assess usability of the EHR. This infrastructure has led to a number of publications and Dr. Gold has received grants from AHRQ to conduct this research. Recently, Dr. Gold has expanded this work to include understanding how all member of the interprofessional team (Nurses, pharmacists physicians etc….) interact with the EHR during ICU rounds. This was funded initially through a grant by the Donaghue foundation and AAMC and has since received additional RO1 funding from AHRQ.  In addition, this work is now part of the National Center for Interprofessional Care’s “NEXUS” network.

In part based on his work with EHR based simulation, Dr. Gold was appointed co-director of OHSU simulation in 2013, and in 2015 appointed Director of Simulation for OHSU.

Read more


  • M.D., New York University School of Medicine, New York New York 1995
  • Residency:

    • Internal medicine, Columbia Presbyterian Medical Center, 1995
  • Fellowship:

    • Pulmonary and critical care medicine, NYU Medical Center, NY 1998
  • Certifications:

    • American Board of Internal Medicine, internal medicine, 1998
    • American Board of Internal Medicine, Pulmonary Medicine, 2001
    • American Board of Internal Medicine, Critical Care Medicine, 2002

Memberships and associations

  • American Foundation for Medical Research
  • American Thoracic Society
  • Society for Critical Care Medicine
  • American College of Chest Physicians


  • "Erratum" Journal of Immunology December 15 2006
  • "A strategy of escalating doses of benzodiazepines and phenobarbital administration reduces the need for mechanical ventilation in delirium tremens" Critical Care Medicine March 2007
  • "The role of cyclooxygenase-2 in mechanical ventilation-induced lung injury" American Journal of Respiratory Cell and Molecular Biology September 2012
  • "Differential role for CD80 and CD86 in the regulation of the innate immune response in murine polymicrobial sepsis" PLoS One August 12 2009
  • "Significance of abnormal chest radiograph findings in patients with HIV-1 infection without respiratory symptoms" Chest  2002
  • "CD40 but not CD154 knockout mice have reduced inflammatory response in polymicrobial sepsis" Shock December 2004
  • "Interleukin 5 is protective during sepsis in an eosinophil-independent manner" American Journal of Respiratory and Critical Care Medicine August 1 2012
  • "Dobutamine stress testing in the cardiac catheterization laboratory" American Journal of Cardiology August 1 1996
  • "Racial variations in the incidence of severe alcohol withdrawal" Journal of Medical Toxicology  2009
  • "OX40 ligand regulates inflammation and mortality in the innate immune response to sepsis" Journal of Immunology October 15 2010
  • "Surfactant Protein A Modulates the Inflammatory Response in Macrophages during Tuberculosis" Infection and Immunity February 2004
  • "Hut lung" Medicine; analytical reviews of general medicine, neurology, psychiatry, dermatology, and pediatries  2000
  • "Alcohol withdrawal syndromes in the intensive care unit" Critical Care Medicine September 2010
  • "Exogenous Gamma and Alpha/Beta Interferon Rescues Human Macrophages from Cell Death Induced by Bacillus anthracis" Infection and Immunity March 2004
  • "Mechanisms of polymorphonuclear neutrophil-mediated induction of HIV-1 replication in macrophages during pulmonary tuberculosis" Journal of Infectious Diseases May 1 2007
  • "Aerosolized Gamma Interferon (IFN-γ) Induces Expression of the Genes Encoding the IFN-γ-Inducible 10-Kilodalton Protein but Not Inducible Nitric Oxide Synthase in the Lung during Tuberculosis" Infection and Immunity March 2004
  • "Vascular endothelial growth factor blockade reduces plasma cytokines in a murine model of polymicrobial sepsis" Inflammation October 2004
  • "Mouse eosinophils possess potent antibacterial properties in vivo" Infection and Immunity November 2009
  • "CD40 and CD80/86 act synergistically to regulate inflammation and mortality in polymicrobial sepsis" American Journal of Respiratory and Critical Care Medicine February 1 2008
  • "Chest radiographs in HIV-infected persons [3] (multiple letters)" Chest April 1 2003
  • "Mycobacterium tuberculosis-Induced CXCR4 and Chemokine Expression Leads to Preferential X4 HIV-1 Replication in Human Macrophages" Journal of Immunology May 15 2004
  • "Gene expression profiles of bronchoalveolar cells in pulmonary TB" Tuberculosis January 2008
  • "Use of simulation to assess electronic health record safety in the intensive care unit" BMJ Open  2013
  • "Vasopressin as an alternative to norepinephrine in the treatment of milrinone-induced hypotension" Critical Care Medicine  2000
  • "The role of eosinophils in non-parasitic infections" Endocrine, Metabolic and Immune Disorders - Drug Targets June 2011
  • "Catapult-like release of mitochondrial DNA by eosinophils contributes to antibacterial defense" Nature Medicine September 2008
  • "Benzodiazepine administration and need for mechanical ventilation in delirium tremens [22]" Critical Care Medicine July 2007
  • "Intermittent mechanical tricuspid valve obstruction recognized by central venous pressure tracing and confirmed by transesophageal echocardiography." Journal of the American College of Cardiology September 4 2012
  • "CD40 contributes to lethality in acute sepsis" Infection and Immunity June 1 2003
  • "Vasopressin in the treatment of milrinone-induced hypotension in severe heart failure" American Journal of Cardiology February 15 2000

Additional information

Edit profile